SPDR S&P Biotech ETF $XBI Shares Purchased by Royal Fund Management LLC

Royal Fund Management LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 67,521 shares of the exchange traded fund’s stock after purchasing an additional 4,208 shares during the quarter. Royal Fund Management LLC’s holdings in SPDR S&P Biotech ETF were worth $5,600,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Commerce Bank lifted its stake in shares of SPDR S&P Biotech ETF by 36.5% in the first quarter. Commerce Bank now owns 4,356 shares of the exchange traded fund’s stock worth $353,000 after buying an additional 1,164 shares in the last quarter. Belvedere Trading LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at about $274,000. Bristlecone Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 25.5% in the 1st quarter. Bristlecone Advisors LLC now owns 23,900 shares of the exchange traded fund’s stock valued at $1,938,000 after acquiring an additional 4,852 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in SPDR S&P Biotech ETF by 625.1% in the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after purchasing an additional 12,344,558 shares in the last quarter. Finally, Mizuho Markets Americas LLC purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth approximately $4,189,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $123.25 on Friday. The stock’s 50 day simple moving average is $110.87 and its 200-day simple moving average is $95.34. The stock has a market cap of $7.48 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $123.61.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.